Jim McDonald
Angel Investor @ University of Strathclyde
Glasgow, United Kingdom
Jim McDonald is a seed investor at University of Strathclyde in Glasgow focused on Medical and Health Care. Professor Sir Jim McDonald joined Strathclyde University in 1984 and was appointed Rolls-Royce Professor of Electrical Power Systems in 1993. He advises government, industry and commerce on power networks, distributed generation and renewable energy. He is Chairman of the Institute for Energy and Environment, the largest power engineering andenergy systems research group internationally. He was appointed Deputy Principal in 2006 focussing on research enhancement and commercialisation.In August 2009 he was appointed as Chairman of the Scottish Research Partnership in Engineering (SRPE), part of a major research pooling investment across Scotland. He is a member of the Scottish Enterprise Board and was a member of the UK Trade and Investment Energy Excellence Board. He Chairs the Scottish Energy Technology Partnership (ETP) that involves the energy research intensive Scottish universities. He co-chairs (with the First Minister) the Energy Advisory Board in Scotland. He became Principal and Vice-Chancellor of the University of Strathclyde in March 2009. He is Chairman of the Independent Economic Commission for the City of Glasgow, and Chairman of the Board of the Glasgow Science Centre.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Jim McDonald invests in
Stages Jim McDonald invests in
Countries Jim McDonald invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
- Internet of Things 1 (33%)
- Telecommunications 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| R3 IoT enables organisations to access their critical operational data by automating the collection of sensor data. This data is transferred from remote operations to the cloud via satellite providing business leaders and operational management the capability to make better decisions and reduce inefficiencies. | $3.9M / Seed / Sep 12, 2023 | ||
| Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.Microplate Dx, an award-winning spinout company from the University of Strathclyde in Glasgow, focuses on creating innovative diagnostic solutions to combat the significant global health challenge of antimicrobialresistance. Their technology revolves around the ingenious concept of employing highly sensitive biosensor electrodes, enhanced with miniaturized hydrogel deposits containing various antibiotics tailored to the specific infection being detected. The primary mission of Microplate DX is to proactively prevent and manage the proliferation of antimicrobial resistance on a global scale. | $3.3M / Seed / Sep 11, 2023 | ||
| R3 IoT enables organisations to access their critical operational data by automating the collection of sensor data. This data is transferred from remote operations to the cloud via satellite providing business leaders and operational management the capability to make better decisions and reduce inefficiencies. | $4.3M / Seed / Jul 27, 2021 |
Co-Investors
The University of Strathclyde provides higher education programs across undergraduate, postgraduate, and research levels, with a focus on teaching, applied research, and knowledge exchange. The institution offers postgraduate taught and research degrees, supported by a range of scholarship options designed to assist students with academicprogression. Research activity spans multiple disciplines and informs curriculum development, industry collaboration, and public impact initiatives.
University of Strathclyde Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Craig Clark
Professor of Practice, Space
|
|||
Lilian Edwards
Professor of Internet Law
|
|||
Pawel Niewczas
Professor
|
|||
Cameron Graham
Entrepreneurial Ambassador
|
|||
Campbell Booth
Vice Dean - Research
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jim McDonald invest in?
Jim McDonald invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jim McDonald?
Public channels for Jim McDonald include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jim McDonald last invest?
The most recent investment recorded for Jim McDonald closed in Sep 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
